Researchers at the University of Akron have revealed the evolutionary strength of spider web glue. Published in the May 17, 2010, issue of Nature Communications, the research revealed that the effectiveness and strength of the spider web glue ensues from the highly entangled, cross-linked polymers in each droplet of the glue, which enables the adhesive [...]
¶
Posted 17 May 2010
† P. Driscoll
§
biomaterials § innovation § medtech § surgical glue § surgical sealant § wound management
‡
°
Also tagged: dermabond, fibrin, fibrin glue, fibrin sealant, hemostasis, market data, medical adhesive, medtech, sealant, surgical glue, surgical sealant, suture, sutures, wound, wound closure
Diverse technologies have a surprising number of common threads, whether in the technologies themselves or in the clinical applications. For this reason, manufacturers need to consider that: 1. A technology platform can be the launchpad for products in clinically diverse areas. Case in point, cell therapy, which as a fundamental scientific discipline can have uses [...]
¶
Posted 23 March 2010
† P. Driscoll
§
cell therapy § clinical practice § innovation § market data § medtech § surgical glue § surgical sealant § tissue engineering § wound management
‡
°
Also tagged: bioglue, cardiology, cyanoacrylate, dermabond, fibrin glue, fibrin sealant, glue, high-strength glue, market data, markets, medical adhesive, medical glue, medical sealant, medical technology, medtech, reports, sealant, sealants, staple, staples, surgial sealant, surgical adhesive, surgical staple, tissue regeneration, trend, wound, wound management, wound sealant, wound therapy, woundcare, wounds
Products and technologies used in advanced wound management have found varying degrees of success in global markets, stemming from differences in clinical practices, cultures, sensitivities, demographics and other geographically-driven differences. At the macro view, the size of the advanced wound management market by countries falls in a typical pattern based on the relative size of [...]
A considerable number and type of different biologically-based glues and adhesives are being studied for their potential use in human applications for wound closure. We previously addressed this in our post Sandcastle worms, mussels, burrowing frogs and gecko feet. To that list, we can now add a glycoprotein web glue from the golden orb weaving [...]
Following on the post, What medtech company isn’t globally focused?, the premise of which is that opportunities are too large globally to focus on one geographic, especially considering the competition, it is important to understand how the dynamics of each market can come to be understood in juxtaposition with each other. Each market has its [...]
The terms “sealant” and “glue” tend to be used interchangeably in the surgical context, but in fact there is a difference in adhesive strength between sealants, pioneered by fibrin products (sometimes homemade) and the later, stronger glues of which cyanoacrylate-based products were the leaders. Fibrin sealants represented a revolution in local hemostatic measures for both [...]
Below is a brief profile of Adhezion Biomedical, LLC, one of the companies active in the surgical sealants and glues market and profiled in the MedMarket Diligence report #S175. We occasionally highlight companies whose products, in our opinion, are poised to make an impact on medtech markets. Founded in 2001, Adhezion Biomedical (formerly Spartan Medical [...]
¶
Posted 14 October 2009
† P. Driscoll
§
Cosmetic/aesthetic § biomaterials § biopharmaceutical § early stage company § innovation § market data § medtech § startups § surgery § surgical glue § surgical sealant § wound management
‡
°
Also tagged: chronic wound, decubitus ulcer, economy, fibrin glue, fibrin sealant, financing, innovation, investment, medtech, seed stage, series a, series b, series c, series d, startup, surgical glue, surgical sealant, surgical staple, suture, wound closure, wound dressing
Hemostats have been used for over a hundred years to stop bleeding in surgical and traumatic wounds. Primarily these products were first introduced to prevent hematomas during surgery with the aim of preventing resultant infections. During the 1980s and 1990s, the popularity of hemostats increased rapidly as surgeons tried to avoid excessive use of blood transfusions [...]
The use of fibrin and other hemostats expanded rapidly in the 1980s in Japan, driven by the strong cultural desire to avoid the need for blood transfusions. In addition, regulatory barriers to launching homologous pooled plasma-derived products in Europe were not as stringent as those imposed by the U.S. FDA in the late 1980s and [...]
Today at the 95th Annual Clinical Congress of the American College of Surgeons, Covidien introduced its V-Loc absorbable device for knotless, soft tissue repair. "The V-Loc device is a breakthrough in dermal wound closure technology, and the feedback we are getting from surgeons who have tested the device is overwhelmingly enthusuastic," said Dr. Michael Tarnoff, [...]